par Bosly, André;Sonet, Anne;Pinkerton, C Ross;McCowage, Geoffrey;Bron, Dominique
;Sanz, Miguel A;Van den Berg, Hendrik
Référence Cancer, 98, 5, page (1048-1054)
Publication Publié, 2003-09

Référence Cancer, 98, 5, page (1048-1054)
Publication Publié, 2003-09
Article révisé par les pairs
Titre: |
|
Auteur: | Bosly, André; Sonet, Anne; Pinkerton, C Ross; McCowage, Geoffrey; Bron, Dominique; Sanz, Miguel A; Van den Berg, Hendrik |
Informations sur la publication: | Cancer, 98, 5, page (1048-1054) |
Statut de publication: | Publié, 2003-09 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Acute leukemia |
Compassionate use | |
Hemodialysis | |
Hyperuricemia | |
Non-Hodgkin lymphoma | |
Rasburicase (Fasturtec®/Elitek®) | |
Tumor lysis syndrome | |
MeSH keywords: | Adolescent |
Adult | |
Aged | |
Aged, 80 and over | |
Child | |
Child, Preschool | |
Female | |
Humans | |
Hyperuricemia -- drug therapy | |
Hyperuricemia -- etiology | |
Infant | |
Infusions, Intravenous | |
Lymphoma, Non-Hodgkin -- complications | |
Lymphoma, Non-Hodgkin -- drug therapy | |
Male | |
Middle Aged | |
Recombinant Proteins | |
Treatment Outcome | |
Tumor Lysis Syndrome -- drug therapy | |
Tumor Lysis Syndrome -- etiology | |
Urate Oxidase -- pharmacology | |
Urate Oxidase -- therapeutic use | |
Note générale: | Clinical Trial |
Journal Article | |
FLWIN | |
Langue: | Anglais |
Identificateurs: | urn:issn:0008-543X |
info:doi/10.1002/cncr.11612 | |
info:scp/0041887047 | |
info:pmid/12942574 |